Investigating the stabilisation of IFN-α2a by replica exchange molecular dynamics simulation

J Mol Model. 2022 Jul 26;28(8):232. doi: 10.1007/s00894-022-05212-w.

Abstract

Current biopharmaceutical drugs are mainly a class of peptides or proteins that play an essential role in the treatment of many diseases. Such peptides/proteins are usually thermally unstable and may lose their bioactivity when exposed to ambient conditions. Therefore, they are not suitable for long-term storage. Lyophilisation is the most common method to prolong shelf life of solid peptide/protein drugs; however, the freeze-drying process can lead to irreversible damage. In the present study, human interferon-alpha 2a (IFN-α2a) was selected as a model protein drug; four disaccharides (β-lactose, β-maltose, sucrose, and trehalose) were selected as bioactive protectants. We investigated the effects of different protectants on IFN-α2a under various ambient conditions (vacuum, dry state, and aqueous solution) using replica exchange molecular dynamics simulation. The protective effect of β-maltose on IFN-α2a was the highest in aqueous solution and dry state, β-lactose showed a poor protective effect in all three conditions, the performance of sucrose was good in all conditions, and trehalose showed a better protective effect under vacuum conditions and in aqueous solution. Disaccharides form H-bonds with water, thereby preventing water from the tertiary structure of proteins. Trehalose forms strong H-bonds with water which explains its extraordinary stability.

Keywords: Bioactive protectant; Disaccharides; IFNα2a; Molecular dynamics simulation.

MeSH terms

  • Disaccharides / chemistry
  • Disaccharides / pharmacology
  • Humans
  • Lactose / chemistry
  • Maltose* / chemistry
  • Molecular Dynamics Simulation
  • Sucrose / chemistry
  • Trehalose* / chemistry
  • Trehalose* / pharmacology
  • Water / chemistry

Substances

  • Disaccharides
  • Water
  • Sucrose
  • Maltose
  • Trehalose
  • Lactose